Lessons learned from a corporate manufacturer on driving the adoption of nature-based solutions.

Companies are increasingly focused on driving the adoption of nature-based solutions across their organizations. Yet, implementing nature-based solutions within existing regulatory frameworks poses a unique set of challenges. In this paper, we present three nature-based solution case studies from The Dow Chemical Company and The Nature Conservancy's nearly 10-year collaboration.

From ash pond to Riverside Wetlands: Making the business case for engineered natural technologies.

The 2015 announcement of The Dow Chemical Company's (Dow) Valuing Nature Goal, which aims to identify $1 billion in business value from projects that are better for nature, gives nature a spot at the project design table. To support this goal, Dow and The Nature Conservancy have extended their long-standing collaboration and are now working to develop a defensible methodology to support the implementation of the goal. This paper reviews the nature valuation methodology framework developed by the Collaboration in support of the goal.

The effects of cholesterol uptake from high-density lipoprotein subfractions on biliary sterol secretion in rats with essential fatty-acid deficiency.

High-density lipoprotein (HDL) participates in the transfer of cholesterol to the liver, in which it is subsequently excreted into bile as bile acid and cholesterol. In this study, the effect of essential fatty-acid (EFA) deficiency on cholesterol contribution from HDL subfractions to bile was investigated. Rats that were rendered EFA-deficient over 4 weeks displayed changes in their plasma HDL subfractions and liver tissue fatty acids.

Oxidative tyrosylation of high density lipoprotein impairs biliary sterol secretion in rats.

The oxidation of low density lipoprotein plays a central role in the pathogenesis of atherosclerosis. Oxidative modification could also occur in high density lipoprotein (HDL), which may alter reverse cholesterol transport. It has recently been proposed that myeloperoxidase-generated tyrosyl radical may modify HDL.

Iron-salicylate complex induces peroxidation, alters hepatic lipid profile and affects plasma lipoprotein composition.

Iron overload, with its associated toxic effects, has serious health consequences and results in damage to the liver, heart and other organs. Salicylate may be used as the lipophilic carrier, transporting more iron into hepatocytes. In this study, we examined the effect of the combined administration of these compounds on plasma lipid profile and lipoprotein composition, as well as on hepatic lipid concentration.